Stereotactic Radiosurgery for Hemangioblastomas

  • Paul Y. Windisch
  • Erqi L. Pollom
  • Scott G. SoltysEmail author


Hemangioblastomas are rare, benign vascular tumors that primarily occur in the posterior fossa and spinal cord. While the majority of cases occur sporadically, 20% of hemangioblastomas are associated with von Hippel-Lindau disease (VHL). Although neurosurgical resection is the standard treatment, stereotactic radiosurgery (SRS) is an alternative option with excellent local control for patients who are not operable or do not desire surgical resection. We review the efficacy and toxicity of SRS for hemangioblastomas in the brain and spinal cord.


Hemangioblastoma Stereotactic radiosurgery Posterior fossa Spinal cord Tumor von Hippel-Lindau disease 


  1. 1.
    Ostrom QT, Gittleman H, Xu J, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009–2013. Neuro Oncol. 2016;18(Suppl 5):v1–v75.CrossRefPubMedGoogle Scholar
  2. 2.
    Asthagiri AR, Mehta GU, Zach L, et al. Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel–Lindau disease. Neuro Oncol. 2010;12(1):80–6.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Kano H, Niranjan A, Mongia S, et al. The role of stereotactic radiosurgery for intracranial hemangioblastomas. Neurosurgery. 2008;63(3):443–50. discussion 450–1.PubMedGoogle Scholar
  4. 4.
    Bamps S, Calenbergh FV, Vleeschouwer SD, et al. What the neurosurgeon should know about hemangioblastoma, both sporadic and in Von Hippel-Lindau disease: a literature review. Surg Neurol Int. 2013;4:145.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    CBTRUS. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2004–2008 (March 23, 2012 revision). Source: Central Brain Tumor Registry of the United States, Hinsdale, IL; 2012.
  6. 6.
    Maher ER, Yates JR, Harries R, et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 1990;77(283):1151–63.CrossRefPubMedGoogle Scholar
  7. 7.
    Bader HL, Hsu T. Systemic VHL gene functions and the VHL disease. FEBS Lett. 2012;586(11):1562–9.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Maher ER, Neumann HP, Richard S. von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet. 2011;19(6):617–23.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Decker J, Neuhaus C, Macdonald F, et al. Clinical utility gene card for: von Hippel–Lindau (VHL). Eur J Hum Genet. 2013;22(4).
  10. 10.
    Shankar GM, Taylor-Weiner A, Lelic N, et al. Sporadic hemangioblastomas are characterized by cryptic VHL inactivation. Acta Neuropathol Commun. 2014;2:167.CrossRefPubMedGoogle Scholar
  11. 11.
    Na JH, Kim HS, Eoh W, et al. Spinal cord hemangioblastoma: diagnosis and clinical outcome after surgical treatment. J Korean Neurosurg Soc. 2007;42(6):436–40.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Mandigo CE, Ogden AT, Angevine PD, et al. Operative management of spinal hemangioblastoma. Neurosurgery. 2009;65(6):1166–77.CrossRefPubMedGoogle Scholar
  13. 13.
    Kano H, Shuto T, Iwai Y, et al. Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study. J Neurosurg. 2015;122(6):1469–78.CrossRefPubMedGoogle Scholar
  14. 14.
    Dwarakanath S, Suri A, Sharma BS, et al. Intracranial hemangioblastomas: an institutional experience. Neurol India. 2006;54(3):276–8.CrossRefPubMedGoogle Scholar
  15. 15.
    International Agency for Research on Cancer. WHO classification of tumours of the central nervous system. Geneva: World Health Organization; 2016.Google Scholar
  16. 16.
    Ho VB, Smirniotopoulos JG, Murphy FM, et al. Radiologic-pathologic correlation: hemangioblastoma. AJNR Am J Neuroradiol. 1992;13(5):1343–52.PubMedGoogle Scholar
  17. 17.
    Wanebo JE, Lonser RR, Glenn GM. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel–Lindau disease. J Neurosurg. 2003;98:82–94.CrossRefPubMedGoogle Scholar
  18. 18.
    Ammerman JM, Lonser RR, Dambrosia J, et al. Long-term natural history of hemangioblastomas in patients with von Hippel–Lindau disease: implications for treatment. J Neurosurg. 2006;105(2):248–55.CrossRefPubMedGoogle Scholar
  19. 19.
    Matsunaga S, Shuto T, Inomori S, et al. Gamma knife radiosurgery for intracranial haemangioblastomas. Acta Neurochir. 2007;149(10):1007–13. discussion 1013CrossRefPubMedGoogle Scholar
  20. 20.
    Wu P, Liang C, Wang Y, et al. Microneurosurgery in combination with endovascular embolisation in the treatment of solid haemangioblastoma in the dorsal medulla oblongata. Clin Neurol Neurosurg. 2013;115(6):651–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Li X, Wang J, Niu J, et al. Diagnosis and microsurgical treatment of spinal hemangioblastoma. Neurol Sci. 2016;37(6):899–906.CrossRefPubMedGoogle Scholar
  22. 22.
    Lonser RR, Weil RJ, Wanebo JE. Surgical management of spinal cord hemangioblastomas in patients with von Hippel–Lindau disease. J Neurosurg. 2003;98:106–16.CrossRefPubMedGoogle Scholar
  23. 23.
    Smalley SR, Schomberg PJ, Earle JD, et al. Radiotherapeutic considerations in the treatment of hemangioblastomas of the central nervous system. Int J Radiat Oncol Biol Phys. 1990;18(5):1165–71.CrossRefPubMedGoogle Scholar
  24. 24.
    Koh E-S, Nichol A, Millar B-A, et al. Role of fractionated external beam radiotherapy in hemangioblastoma of the central nervous system. Int J Radiat Oncol Biol Phys. 2007;69(5):1521–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Puataweepong P, Dhanachai M, Hansasuta A, et al. The clinical outcome of intracranial hemangioblastomas treated with linac-based stereotactic radiosurgery and radiotherapy. J Radiat Res. 2014;55(4):761–8.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Hanakita S, Koga T, Shin M, et al. The long-term outcomes of radiosurgery for intracranial hemangioblastomas. Neuro Oncol. 2014;16(3):429–33.CrossRefPubMedGoogle Scholar
  27. 27.
    Selch MT, Tenn S, Agazaryan N, et al. Image-guided linear accelerator-based spinal radiosurgery for hemangioblastoma. Surg Neurol Int. 2012;3:73.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Daly ME, Choi CYH, Gibbs IC, et al. Tolerance of the spinal cord to stereotactic radiosurgery: insights from hemangioblastomas. Int J Radiat Oncol Biol Phys. 2011;80(1):213–20.CrossRefPubMedGoogle Scholar
  29. 29.
    Sayer FT, Nguyen J, Starke RM, et al. Gamma knife radiosurgery for intracranial hemangioblastomas—outcome at 3 years. World Neurosurg. 2011;75(1):99–105. discussion 45–8CrossRefPubMedGoogle Scholar
  30. 30.
    Karabagli H, Genc A, Karabagli P, et al. Outcomes of gamma knife treatment for solid intracranial hemangioblastomas. J Clin Neurosci. 2010;17(6):706–10.CrossRefPubMedGoogle Scholar
  31. 31.
    Pan J, Ho AL, D’Astous M, et al. Image-guided stereotactic radiosurgery for treatment of spinal hemangioblastoma. Neurosurg Focus. 2017;42(1):E12.CrossRefPubMedGoogle Scholar
  32. 32.
    Wind JJ, Bakhtian KD, Sweet JA, et al. Long-term outcome after resection of brainstem hemangioblastomas in von Hippel-Lindau disease. J Neurosurg. 2011;114(5):1312–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Lonser RR, Butman JA, Huntoon K, et al. Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease. J Neurosurg. 2014;120(5):1055–62.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Simone CB 2nd, Lonser RR, Ondos J, et al. Infratentorial craniospinal irradiation for von Hippel-Lindau: a retrospective study supporting a new treatment for patients with CNS hemangioblastomas. Neuro Oncol. 2011;13(9):1030–6.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Jeffreys R. Clinical and surgical aspects of posterior fossa haemangioblastomata. J Neurol Neurosurg Psychiatry. 1975;38(2):105–11.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Daly ME, Luxton G, Choi CYH, et al. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2012;82(5):2025–32.CrossRefPubMedGoogle Scholar
  37. 37.
    Ryu S, Pugh SL, Gerszten PC, et al. RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results. Pract Radiat Oncol. 2014;4(2):76–81.CrossRefPubMedGoogle Scholar
  38. 38.
    Schipani S, Wen W, Jin JY, et al. Spine radiosurgery: a dosimetric analysis in 124 patients who received 18 Gy. Int J Radiat Oncol Biol Phys. 2012;84(5):e571–6.CrossRefPubMedGoogle Scholar
  39. 39.
    Medin PM, Foster RD, van der Kogel AJ, et al. Spinal cord tolerance to single-fraction partial-volume irradiation: a swine model. Int J Radiat Oncol Biol Phys. 2011;79(1):226–32.CrossRefPubMedGoogle Scholar
  40. 40.
    VHL Surveillance guidelines. VHL Alliance. Published 2016. Accessed 24 Jan 2017.

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Paul Y. Windisch
    • 1
  • Erqi L. Pollom
    • 2
  • Scott G. Soltys
    • 2
    Email author
  1. 1.Department of Molecular GeneticsGerman Cancer Research Center (DKFZ)HeidelbergGermany
  2. 2.Department of Radiation OncologyStanford UniversityStanfordUSA

Personalised recommendations